PET studies combining TSPO and amino acid tracers in both preclinical models and in patients with cerebral gliomas demonstrated that the areas with increased accumulation overlap only partially: high TSPO binding can extend beyond the contrast-enhancing tumor mass and even substantially beyond areas with high amino acid uptake in peritumoral areas [35,36] (Figure 4). This evidence concerns the gene TSPO and neoplasm.